Clinical trial Recruiting at 2 sites Phase 2 Interventional Ages 18 to 65

Mobile health technology to help people quit smoking in Laos

Official title: Mobile Health Technology for Personalized Tobacco Cessation Support in Laos

Run by University of Oklahoma · NCT05233228 · Data updated 2026-11-12

This study is testing a mobile app designed to help people in Laos quit smoking by providing personalized support and resources.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment500 (estimated)
SponsorUniversity of Oklahoma
Academic / other
Locations2 sites (Champasak and 1 other locations)
StatusRecruiting
StartedApril 27, 2022
Main results expectedAugust 31, 2026
Study endsAugust 31, 2026
Registry record updatedAugust 15, 2025
Trial IDNCT05233228 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who are current smokers and planning to quit within the next six months.

Probably not a fit

Patients with medical conditions that prevent the use of nicotine replacement therapy or those currently enrolled in other cessation programs may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to develop and evaluate a mobile health (mHealth) intervention tailored for tobacco cessation in Laos, where smoking rates are notably high. The study consists of two main phases: the first phase involves formative research to adapt the intervention content to the local sociocultural context, while the second phase will implement a randomized controlled trial to assess the effectiveness of the intervention. The mHealth approach includes a smartphone-delivered, automated, and personalized behavioral treatment using the Insight™ platform. The goal is to create a sustainable and widely adoptable solution for smoking cessation in the region.

Why it matters

Potential benefit: If successful, this intervention could significantly reduce smoking rates and improve public health outcomes in Laos.

How similar studies have gone: Other studies utilizing mobile health interventions for smoking cessation have shown promising results, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria: (pilot RCT in the R21 Phase and main RCT in the R33 Phase):

1. aged ≥18 years
2. self-reported current combustible cigarette smokers (smoked at least 100 cigarettes in lifetime and currently smoke ≥1 cigarette/day)
3. willing to set a quit date within 2 weeks of study enrollment
4. able to provide written informed consent to participate
5. able to read Lao (score ≥4 points on the Rapid Estimate of Adult Literacy in Medicine-Short Form).

Exclusion Criteria: (pilot RCT in the R21 Phase and main RCT in the R33 Phase)

1. history of a medical condition that precludes use of NRT
2. ineligibility to participate based on medical or psychiatric conditions diagnosed by a physician/clinician
3. enrollment in another cessation program or current use of other cessation medications.

Where it's running

  • Champasak Hospital
    Champasak, Laos
    Recruiting
  • Setthathirath Hospital
    Vientiane, Laos
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.